The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting input from the radiation biology and microbiome research communities ...
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that ...
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented thin-film ...
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 ...
A new vaccine development platform has proven effective in protecting against deadly, hard-to-treat infections caused by multi-drug resistant bacteria, thanks ...
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of ...
In the medical and military fields, antibiotic-resistant bacteria can be formidable foes. Now, University of Florida Health researchers and their ...
New method to assist fast-tracking of vaccines for pre-clinical tests Scientists in Australia have developed a method for the rapid ...
During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to ...
Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase ...
With multiple promising SARS-CoV-2 vaccine candidates now under development, the National Institute of Allergy and Infectious Diseases (NIAID) is looking ...
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a ...
Novel antibiotics are urgently needed to treat the ever-increasing number of drug-resistant infections. Venoms constitute a treasure trove of novel ...
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a ...
In a new study, researchers from the Dangerous Pathogens Team at CSIRO conclude vaccines currently under development for COVID-19 should ...
Dr. Utpal Pal wants to adapt the rabies vaccination platform to produce antibodies that can protect against Borrelia burgdorferi, the ...
There is a global effort to distribute vaccines to poorer countries, but some of the world’s largest countries, including the ...
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today released new documents outlining the ...
More than 28 million people around the world have now contracted COVID-19, and more than 900,000 people have died. Research ...
Several drug makers developing vaccines to counter SARS-CoV-2 plan to issue a public pledge not to seek government approval until ...
